Trade 352

SELL CRM

0.408601052 shares at $166.42 on 2026-05-13

Reasoning

EXECUTION WITH CONFIDENCE ADJUSTMENT: Playbook recommends exit_full on thesis #252 (weak conviction, macro constraints). Current position is 0.4086 shares at $166.45 = ~$68 at-risk. CRM has breached the $170 invalidation from prior thesis and is 8% below cost basis ($186.70). Citi lowered PT to $188 yesterday. May 27 earnings binary is 2 weeks out. REVERSAL CONTEXT: May 12 decision (yesterday) sold 50% citing April CPI at 3.8% and rate-shock regime invalidating pre-earnings constructive assumptions. Today's playbook correctly escalates to full exit. The macro thesis deterioration is substantiated and the binary event proximity (Rule 39 pre-earnings trim discipline) justifies systematic de-risking. Thesis #252 confidence is medium; Rule 44 rate-shock regime is active (CPI 3.8%, rate hike odds 30%); Rule 27 macro cap applies. Exiting full position avoids 2-week binary exposure and redeploys minimal capital (~$68) into cash buffer during fragile macro window. This is a defensive exit consistent with strategy identity (does not average down into weakening positions; treats earnings as binary risk nodes; respects macro regime shifts).

Thesis

CRM is a deeply beaten-down SaaS leader (down 30%+ YTD) with a $25B buyback providing a floor. Q4 FY2026 EPS beat estimates by 25%. However, the stock is under significant pressure: Citigroup lowered PT to $188, Wells Fargo maintains Hold, extended renewal cycles are concerning, and CRM earnings are May 27 — a binary event in 2 weeks. The position is small and below cost basis. Analyst consensus PT of $279 implies substantial upside, but near-term catalysts are scarce in the current rate-shock macro. The thesis is to hold through earnings as a value/contrarian play with buyback support, but with tight risk management given the macro headwinds. (long, low confidence)

Cited evidence

News